However, they arent designed to solve the underlying causes of nagging joint pain and discomfort
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
However, these findings remain exploratory and non-clinical
All products sold by Polar Peptides are intended strictly for research use only and are not intended for human consumption, medical use, diagnostic use, or any other unauthorized use
Yes, injections work faster and absorb more efficiently especially for those with digestive issues or severe deficiency
These early benefits reflect the anti-inflammatory properties of both peptides rather than structural tissue repair, which requires longer timeframes